Table 2.

Odds Ratios of Respiratory Morbidities with GTs and Nissen/GTs

		Number of Forms [Number of Subjects]	Adjusted Odds Ratio for Risk with GT compared to without GT [95% C.I.]*	Adjusted OR P value	Adjusted Odds Ratio for Risk with Nissen compared to without Nissen [95% C.I.]*	Adjusted OR P value
Primary Outcomes For Respiratory Symptoms	Emergency Department	710 [326]	1.03 [0.62 – 1.72]	0.90	1.38 [0.78 – 2.42]	0.27
	Hospitalization	709 [327]	1.46 [0.81 – 2.61]	0.21	1.96 [1.02 – 3.77]	0.043
	Systemic Steroid Use	703 [325]	1.17 [0.69 – 1.98]	0.57	1.40 [0.79 – 2.49]	0.25
	Antibiotic Use	709 [327]	0.79 [0.47 – 1.32]	0.37	1.22 [0.71 – 2.12]	0.47
Secondary Outcomes	Trouble Breathing	683 [321]	0.64 [0.38 – 1.09]	0.10	0.69 [0.37 – 1.28]	0.24
	Rescue Medication Use	663 [317]	0.88 [0.50 – 1.55]	0.66	1.17 [0.63– 2.21]	0.61
	Activity Limitations	662 [314]	0.63 [0.25 – 1.58]	0.33	0.85 [0.31 – 2.30]	0.75
	Nighttime Symptoms	678 [317]	1.05 [0.55 – 1.99]	0.89	1.34 [0.68 – 2.63]	0.40

^*Logistic regressions clustered by subject and adjusted for age in months at the time of visit, presence of supplemental oxygen, presence of home ventilation, small for gestational age status, insurance status, and any inhaled corticosteroid use between 0–2 years of age. Only data obtained prior to 24 months of age was utilized.